Skip to Main Content
Table 5.

Applying sensitivity and specificity estimates from the present meta-analysis to results from the 1998 and 2000 NHIS

Time frame (y)AgesObserved prevalenceSeSpAdjusted prevalence
Mammogram 40+ 70 0.95 0.61 56 
Pap smear 25+ 82 0.93 0.48 74 
PSA test 50+ 41 0.71 0.73 32 
FOBT (women) 50+ 26 0.82 0.78 <10 
FOBT (men) 50+ 29 0.82 0.78 11 
Endoscopy (women) 50+ 10 0.79 0.90 <10 
Endoscopy (men) 50+ 19 0.79 0.90 13 
Time frame (y)AgesObserved prevalenceSeSpAdjusted prevalence
Mammogram 40+ 70 0.95 0.61 56 
Pap smear 25+ 82 0.93 0.48 74 
PSA test 50+ 41 0.71 0.73 32 
FOBT (women) 50+ 26 0.82 0.78 <10 
FOBT (men) 50+ 29 0.82 0.78 11 
Endoscopy (women) 50+ 10 0.79 0.90 <10 
Endoscopy (men) 50+ 19 0.79 0.90 13 

NOTE: Mammogram, Pap smear, and PSA prevalence estimates are from the 2000 NHIS; FOBT and endoscopy prevalence estimates are from the 1998 NHIS.

Close Modal

or Create an Account

Close Modal
Close Modal